|
US3009864A
(en)
|
1958-09-18 |
1961-11-21 |
Union Carbide Corp |
Process control
|
|
US3228838A
(en)
|
1959-04-23 |
1966-01-11 |
Union Carbide Corp |
Preservation of biological substances
|
|
US3009861A
(en)
|
1961-01-13 |
1961-11-21 |
Alderton Gordon |
Isolation of bacterial spores
|
|
US3608030A
(en)
|
1969-05-21 |
1971-09-21 |
Howard Tint |
Method of preparing a tablet dosage-form for the immunization of the intestinal tract with live virus preparations
|
|
US4077227A
(en)
|
1976-11-12 |
1978-03-07 |
Regents Of The University Of Minnesota |
Method of freezing liquid material in which agglomeration is inhibited
|
|
US4205132A
(en)
|
1978-07-17 |
1980-05-27 |
Microlife Technics, Inc. |
Lyophilization of bacteria
|
|
FI59925C
(fi)
|
1980-01-11 |
1981-11-10 |
Esko Viljo Nurmi |
Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
|
|
US4655047A
(en)
|
1985-03-25 |
1987-04-07 |
I.Q.F. Inc. |
Process for freezing or chilling
|
|
JPS61252212A
(ja)
|
1985-04-12 |
1986-11-10 |
Mitsubishi Petrochem Co Ltd |
高吸水性ポリマ−の製造方法
|
|
US4839281A
(en)
|
1985-04-17 |
1989-06-13 |
New England Medical Center Hospitals, Inc. |
Lactobacillus strains and methods of selection
|
|
US5196205A
(en)
|
1987-10-12 |
1993-03-23 |
Borody Thomas J |
Method for treatment of gastro intestinal disorders
|
|
US5045446A
(en)
|
1988-08-26 |
1991-09-03 |
Cryopharm Corporation |
Lyophilization of cells
|
|
CA1333564C
(en)
|
1988-08-02 |
1994-12-20 |
Thomas Julius Borody |
Treatment of gastro-intestinal disorders
|
|
US5443826A
(en)
|
1988-08-02 |
1995-08-22 |
Borody; Thomas J. |
Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
|
|
GB2233343B
(en)
|
1989-06-30 |
1993-07-07 |
Farmos Oy |
A bacterial preparation for use in poultry
|
|
JP2961182B2
(ja)
|
1990-03-09 |
1999-10-12 |
ミヤリサン株式会社 |
クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物
|
|
JP2961184B2
(ja)
|
1990-05-07 |
1999-10-12 |
ミヤリサン株式会社 |
クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物
|
|
US5436002A
(en)
|
1991-01-29 |
1995-07-25 |
Mycogen Corporation |
Bacillus thuringiensisisolate PS201T6 toxin
|
|
RU2035186C1
(ru)
|
1992-07-09 |
1995-05-20 |
Семен Рафаилович Резник |
Профилактический биопрепарат споролакт
|
|
KR950703640A
(ko)
|
1992-10-09 |
1995-09-20 |
가일 케이,나우톤. |
간 보존 세포(liver reserve cells)
|
|
US5599795A
(en)
|
1994-08-19 |
1997-02-04 |
Mccann; Michael |
Method for treatment of idiopathic inflammatory bowel disease (IIBD)
|
|
ATE310391T1
(de)
|
1995-09-15 |
2005-12-15 |
Dale N Gerding |
Verfahren und zusammensetzung zur vorbeugung und behandlung von mit clostridium difficile assoziierten erkrankungen
|
|
AUPO430496A0
(en)
|
1996-12-19 |
1997-01-23 |
Arnott's Biscuits Limited |
Prebiotics and probiotics
|
|
US5965128A
(en)
|
1997-08-13 |
1999-10-12 |
University Of Georgia Research Foundation Inc. |
Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
|
|
US5951977A
(en)
|
1997-10-14 |
1999-09-14 |
The United States Of America, As Represented By The Secretary Of Agriculture |
Competitive exclusion culture for swine
|
|
US6461607B1
(en)
|
1998-08-24 |
2002-10-08 |
Ganeden Biotech, Inc. |
Probiotic, lactic acid-producing bacteria and uses thereof
|
|
US6589771B1
(en)
|
1999-10-28 |
2003-07-08 |
Immunom Technologies, Inc. |
Methods for arousing dormant bacteria
|
|
US20030118547A1
(en)
|
2000-01-27 |
2003-06-26 |
Vandenberg Grant William |
Composition for intestinal delivery
|
|
AU2001233529A1
(en)
|
2000-02-10 |
2001-08-20 |
Andrew W. Bruce |
Probiotic therapy for newborns
|
|
US20020013270A1
(en)
|
2000-06-05 |
2002-01-31 |
Bolte Ellen R. |
Method for treating a mental disorder
|
|
US20040170617A1
(en)
|
2000-06-05 |
2004-09-02 |
Finegold Sydney M. |
Method of treating diseases associated with abnormal gastrointestinal flora
|
|
AUPQ899700A0
(en)
*
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
|
PL366363A1
(en)
|
2000-11-30 |
2005-01-24 |
The Bio Balance Corp. |
Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
|
|
NZ529910A
(en)
|
2001-05-04 |
2007-03-30 |
Univ Florida |
Cloning and sequencing of pyruvate decarboxylase (PDC) genes from bacteria and uses therefor
|
|
ITMI20011632A1
(it)
|
2001-07-27 |
2003-01-27 |
Sanofi Synthelabo |
Composizione solida contenente spore di batteri non patogeni del genere bacillus
|
|
GB0130789D0
(en)
|
2001-12-21 |
2002-02-06 |
King S College London |
Application of spores
|
|
US8383342B2
(en)
|
2002-04-24 |
2013-02-26 |
The University Of North Carolina At Greensboro |
Compositions, products, methods and systems to monitor water and other ecosystems
|
|
GB0212975D0
(en)
|
2002-06-06 |
2002-07-17 |
Mars Uk Ltd |
Mammalian animal composition
|
|
AU2002951692A0
(en)
|
2002-09-23 |
2002-10-17 |
Vital Biotech (Hong Kong) Limited |
Improvements in or relating to vaccines
|
|
AU2003303894A1
(en)
|
2003-01-30 |
2004-08-30 |
The Regents Of The University Of California |
Inactivated probiotic bacteria and methods of use thereof
|
|
US8617870B2
(en)
|
2003-03-13 |
2013-12-31 |
University Of Ottawa |
Antioxidant producing bacterium and uses thereof
|
|
SG173919A1
(en)
|
2003-04-23 |
2011-09-29 |
Medarex Inc |
Compositions and methods for the therapy of inflammatory bowel disease
|
|
US20060046246A1
(en)
|
2003-04-24 |
2006-03-02 |
Qiandong Zeng |
Genus, group, species and/or strain specific 16S rDNA sequences
|
|
WO2004104175A2
(en)
|
2003-05-14 |
2004-12-02 |
University Of Georgia Research Foundation, Inc. |
Probiotic bacteria and methods
|
|
WO2005017095A2
(en)
|
2003-08-18 |
2005-02-24 |
The Bio Balance Corporation |
A stable liquid probiotic composition, preparation and applications thereof
|
|
US20050048515A1
(en)
|
2003-08-29 |
2005-03-03 |
Garner Bryan E. |
Methods for detecting and quantifying specific probiotic microorganisms in animal feed
|
|
US7731976B2
(en)
|
2003-08-29 |
2010-06-08 |
Cobb And Company, Llp |
Treatment of irritable bowel syndrome using probiotic composition
|
|
US20050239706A1
(en)
|
2003-10-31 |
2005-10-27 |
Washington University In St. Louis |
Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject
|
|
US20050158294A1
(en)
|
2003-12-19 |
2005-07-21 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria pseudolongum
|
|
HUE024565T2
(hu)
|
2004-02-03 |
2016-02-29 |
Prevtec Microbia Inc |
Élõ baktériumok alkalmazása növekedésserkentésre állatokban
|
|
US7632520B2
(en)
|
2004-02-16 |
2009-12-15 |
Sanjeev Khandelwal |
Synergistic antibacterial formulation and to a method of making the same
|
|
US7854927B2
(en)
|
2004-05-11 |
2010-12-21 |
Ganeden Biotech, Inc. |
Methods and compositions for the dietary management of autoimmune disorders
|
|
US20090197249A1
(en)
|
2004-11-01 |
2009-08-06 |
George Mason University |
Compositions and methods for diagnosing colon disorders
|
|
CA2586299C
(en)
|
2004-11-01 |
2014-10-28 |
James W. Stave |
Method for detecting or enriching a target microorganism upon lysis of non-target bacteria with bacteriophage
|
|
US20060188523A1
(en)
|
2005-01-10 |
2006-08-24 |
Zhiheng Pei |
Methods for diagnosing and treating chronic tonsillitis
|
|
US7993667B2
(en)
|
2005-03-25 |
2011-08-09 |
Kimberly-Clark Worldwide, Inc. |
Methods of manufacturing a medicated tampon assembly
|
|
EP1885383B1
(en)
|
2005-05-31 |
2016-09-21 |
IAMS Europe B.V. |
Feline probiotic bifidobacteria
|
|
US7452872B2
(en)
|
2005-08-24 |
2008-11-18 |
Salix Pharmaceuticals, Inc. |
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
|
|
PL1931363T3
(pl)
|
2005-09-28 |
2016-06-30 |
Nordic Rebalance As |
Leczenie IBD z zastosowaniem zarówno bakterii probiotycznych, jak i sfermentowanych zbóż jako efektorów leczenia
|
|
US8968721B2
(en)
|
2005-12-28 |
2015-03-03 |
Advanced Bionutrition Corporation |
Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
|
|
WO2007136553A2
(en)
|
2006-05-18 |
2007-11-29 |
Biobalance Llc |
Bacterial strains, compositions including same and probiotic use thereof
|
|
JP5019563B2
(ja)
|
2006-06-16 |
2012-09-05 |
旭化成ケミカルズ株式会社 |
腸内細菌賦活剤
|
|
CN101472639A
(zh)
|
2006-06-20 |
2009-07-01 |
皇家飞利浦电子股份有限公司 |
用于治疗胃肠疾病的电子胶囊
|
|
TW200819540A
(en)
|
2006-07-11 |
2008-05-01 |
Genelux Corp |
Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
|
|
EE05459B1
(et)
|
2006-12-08 |
2011-08-15 |
Tartu �likool |
Sporogeense Bacillus smithii tvi TBMI12 MSCL P737 ja selle endospooride kasutamine probiootikumina, toidulisandina ning probiootiline kompositsioon
|
|
US20100172874A1
(en)
|
2006-12-18 |
2010-07-08 |
The Washington University |
Gut microbiome as a biomarker and therapeutic target for treating obesity or an obesity related disorder
|
|
DE102006062250A1
(de)
|
2006-12-22 |
2008-06-26 |
Roland Saur-Brosch |
Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden
|
|
WO2008083157A2
(en)
|
2006-12-29 |
2008-07-10 |
Washington University In St. Louis |
Altering pgc-1alapha, ampk, fiaf, or the gastrointestinal microbiota as a means to modulate body fat and/or weight loss in a subject
|
|
EP2195004B1
(en)
|
2007-09-12 |
2015-04-01 |
The Medicines Company |
Method of inhibiting clostridium difficile by administration of oritavancin
|
|
US8469648B2
(en)
*
|
2007-10-24 |
2013-06-25 |
T&T Engineering Services |
Apparatus and method for pre-loading of a main rotating structural member
|
|
JP2011503232A
(ja)
|
2007-11-20 |
2011-01-27 |
ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド |
免疫応答の調節
|
|
US8236508B2
(en)
|
2008-01-29 |
2012-08-07 |
Drexel University |
Detecting and measuring live pathogens utilizing a mass detection device
|
|
US8021654B2
(en)
|
2008-03-14 |
2011-09-20 |
Danisco A/S |
Methods of treating pigs with Bacillus strains
|
|
KR20100134080A
(ko)
|
2008-04-01 |
2010-12-22 |
메타메트릭스 클리니칼 레보러토리 |
위장의 미생물상을 모니터링하기 위한 공정과 방법
|
|
CN102940652B
(zh)
|
2008-05-28 |
2015-03-25 |
青岛东海药业有限公司 |
两形真杆菌制剂及其应用
|
|
US20110113863A1
(en)
|
2008-07-15 |
2011-05-19 |
Metanomics Health Gmbh |
Means and methods diagnosing gastric bypass and conditions related thereto
|
|
JPWO2010024251A1
(ja)
|
2008-08-26 |
2012-01-26 |
オリンパス株式会社 |
糞便試料の調製方法、糞便試料調製用溶液、及び採便用キット
|
|
WO2010030997A1
(en)
|
2008-09-12 |
2010-03-18 |
The Washington University |
Regulating intestinal microbiota dependent signaling as a means to modulate body fat and/or weight loss
|
|
EP2337569A4
(en)
|
2008-09-25 |
2013-04-03 |
Univ New York |
COMPOSITIONS AND METHODS FOR CHARACTERIZING AND RESTORING THE STOMACH DARM, SKIN AND NOSE MICROBIOTA
|
|
JP5620392B2
(ja)
|
2008-11-03 |
2014-11-05 |
タフツ ユニヴァーシティーＴｕｆｔｓ Ｕｎｉｖｅｒｓｉｔｙ |
クロストリジウム・ディフィシレ胞子の発芽および伸長を阻害するための方法および組成物
|
|
GB0821913D0
(en)
|
2008-12-02 |
2009-01-07 |
Price & Co |
Antibacterial compounds
|
|
IT1393931B1
(it)
|
2009-02-25 |
2012-05-17 |
Neuroscienze Pharmaness S C A R L |
Composizione di spore di batteri non patogeni
|
|
US20120128633A1
(en)
|
2009-04-30 |
2012-05-24 |
Campagnie Gervaise Donone |
Use of collinsella aerofaciens for reducing bloating
|
|
HRP20160598T4
(hr)
|
2009-05-01 |
2019-06-28 |
Uas Laboratories Llc |
Bakterijski sastavi za prevenciju i liječenje degenerativne bolesti
|
|
US9050276B2
(en)
|
2009-06-16 |
2015-06-09 |
The Trustees Of Columbia University In The City Of New York |
Autism-associated biomarkers and uses thereof
|
|
US20120264637A1
(en)
|
2009-06-26 |
2012-10-18 |
The Regents Of The University Of California |
Methods and systems for phylogenetic analysis
|
|
DK2446062T3
(da)
|
2009-06-26 |
2014-10-06 |
Univ California |
Fremgangsmåder og systemer til phylogenetisk analyse
|
|
WO2011005756A1
(en)
|
2009-07-06 |
2011-01-13 |
Puretech Ventures, Llc |
Delivery of agents targeted to microbiota niches
|
|
WO2011020780A1
(en)
|
2009-08-18 |
2011-02-24 |
Nestec S.A. |
A nutritional composition comprising lactococcus strains and reducing allergy symptoms, especially in infants and children.
|
|
WO2011022542A2
(en)
|
2009-08-19 |
2011-02-24 |
Puretech Ventures, Llc |
Administration of factors normally present in a microbial niche to improve health
|
|
WO2011022660A1
(en)
|
2009-08-21 |
2011-02-24 |
Puretech Ventures, Llc |
Methods of diagnosing and treating microbiome-associated disease using interaction network parameters
|
|
GB0916335D0
(en)
|
2009-09-17 |
2009-10-28 |
Martin W J |
Medicaments
|
|
PL2480255T3
(pl)
|
2009-09-23 |
2018-07-31 |
Thomas Julius Borody |
Terapia przewlekłych zakażeń jelitowych
|
|
CA2776420A1
(en)
*
|
2009-10-05 |
2011-04-14 |
Aak Patent B.V. |
Methods for diagnosing irritable bowel syndrome
|
|
US20110081320A1
(en)
|
2009-10-06 |
2011-04-07 |
Nubiome, Inc. |
Treatment/Cure of Autoimmune Disease
|
|
WO2011046616A2
(en)
|
2009-10-15 |
2011-04-21 |
New York University |
Methods for modulating bacterial infection
|
|
PH12012500687A1
(en)
|
2009-11-12 |
2012-10-29 |
Nestec Sa |
Nutritional composition for promoting gut microbiota balance and health
|
|
MX348611B
(es)
|
2009-12-31 |
2017-06-21 |
Milton Trachtman Ira |
Forma de dosificación oral para usarse en el tratamiento de enfermedad inflamatoria de intestino debido a una infección bacteriana.
|
|
AU2011209940B2
(en)
|
2010-02-01 |
2015-08-20 |
Ferring Microbiome Inc. |
Bacteriotherapy for clostridium difficile colitis
|
|
US9492487B2
(en)
|
2010-02-01 |
2016-11-15 |
Matthew Ryan Garner |
Microbial product containing multiple microorganisms
|
|
WO2011103123A2
(en)
|
2010-02-16 |
2011-08-25 |
Arizona Technology Enterprises |
Reducing short-chain fatty acids and energy uptake in obese humans by managing their intestinal microbial communities
|
|
CN102939392A
(zh)
|
2010-03-01 |
2013-02-20 |
国家农艺研究院 |
肥胖的诊断方法
|
|
EP2542690A2
(en)
|
2010-03-01 |
2013-01-09 |
Institut National de la Recherche Agronomique |
Method of diagnostic of inflammatory bowel diseases
|
|
IT1398553B1
(it)
|
2010-03-08 |
2013-03-01 |
Probiotical Spa |
Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
|
|
WO2011113801A1
(en)
|
2010-03-16 |
2011-09-22 |
Universiteit Gent |
Use of clostridium perfringens strain 23 to protect against necrotic enteritis
|
|
US8951512B2
(en)
|
2010-05-04 |
2015-02-10 |
New York University |
Methods for treating bone disorders by characterizing and restoring mammalian bacterial microbiota
|
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
|
|
CA2804492A1
(en)
|
2010-07-06 |
2012-01-12 |
Novartis Ag |
Immunisation of large mammals with low doses of rna
|
|
WO2012009712A2
(en)
|
2010-07-16 |
2012-01-19 |
The Board Of Trustees Of The University Of Arkansas |
Methods and compositions including spore-forming bacteria for increasing the health of animals
|
|
FI20105825A7
(fi)
|
2010-07-26 |
2012-01-27 |
Suomen Punainen Risti Veripalvelu |
Veriryhmästatuksen käyttö III
|
|
KR102435108B1
(ko)
|
2010-08-04 |
2022-08-22 |
핀치 테라퓨틱스 홀딩스 엘엘씨 |
분변 세균총 이식을 위한 조성물, 그의 제조 방법과 사용 방법, 및 그를 전달하기 위한 장치
|
|
WO2012024638A2
(en)
|
2010-08-20 |
2012-02-23 |
New York University |
Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
|
|
WO2012033814A2
(en)
|
2010-09-10 |
2012-03-15 |
Viropharma Incorporated |
Environmental clostridial bacteriotherapy and related formulations and methods of manufacture and use
|
|
KR20140033309A
(ko)
|
2010-10-04 |
2014-03-18 |
브리티쉬 콜롬비아 캔써 에이전시 브랜치 |
위장 암을 진단하기 위해 위장의 샘플에서의 푸소박테리움의 검출
|
|
EP2637650A2
(en)
|
2010-11-10 |
2013-09-18 |
National Jewish Health |
Methods to test allergic conditions
|
|
US20120064592A1
(en)
|
2011-01-26 |
2012-03-15 |
Qteros, Inc. |
Biocatalysts synthesizing deregulated cellulases
|
|
US8927252B2
(en)
|
2011-02-09 |
2015-01-06 |
Lavivo Ab |
Synbiotic compositions for restoration and reconstitution of gut microbiota
|
|
TW201247875A
(en)
|
2011-02-25 |
2012-12-01 |
Tricorder Diagnostics Llc |
Microbial signatures as indicators of radiation exposure
|
|
WO2012122522A2
(en)
|
2011-03-09 |
2012-09-13 |
Washington University |
Cultured collection of gut microbial community
|
|
JP2014507481A
(ja)
|
2011-03-09 |
2014-03-27 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
結腸微生物相移植のための組成物及び方法
|
|
WO2012142605A1
(en)
*
|
2011-04-15 |
2012-10-18 |
Samaritan Health Services |
Rapid recolonization deployment agent
|
|
US20120276056A1
(en)
|
2011-04-26 |
2012-11-01 |
Wieslaw Janusz Bochenek |
Method for Use of Biologic Agents Including Live or Dormant Forms of Bacteria and other organisms in Treating Infections, Inflammation and Other Diseases of Distal Small Intestine and Large Intestine
|
|
WO2012159023A2
(en)
|
2011-05-19 |
2012-11-22 |
Virginia Commonwealth University |
Gut microflora as biomarkers for the prognosis of cirrhosis and brain dysfunction
|
|
US9579353B2
(en)
|
2011-06-10 |
2017-02-28 |
Prothera, Inc. |
Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
|
|
WO2013008102A2
(en)
|
2011-07-14 |
2013-01-17 |
R.E.D. Laboratories N.V../ S.A. |
Methods and compositions for evaluating and/or treating chronic immune diseases
|
|
US20130022575A1
(en)
|
2011-07-19 |
2013-01-24 |
Microbial Rx |
Systems and methods of replacing intestinal flora
|
|
WO2013016636A1
(en)
|
2011-07-27 |
2013-01-31 |
Max International, Llc |
Compositions comprising sugar-cysteine products
|
|
WO2013019896A1
(en)
|
2011-08-01 |
2013-02-07 |
Symbiotix Biotherapies, Inc. |
Platform for identifying and/or characterizing immunomodulatory agents
|
|
CA2851602C
(en)
|
2011-08-30 |
2020-07-14 |
Academisch Medisch Centrum |
Method for preventing and/or treating insulin resistance
|
|
EP2756071B1
(en)
|
2011-09-14 |
2017-12-20 |
University Of Guelph |
Media supplements and methods to culture human gastrointestinal anaerobic microorganisms
|
|
WO2013066369A2
(en)
|
2011-10-03 |
2013-05-10 |
The Regents Of The University Of Michigan |
Methods for detecting graft-versus-host disease
|
|
US20130121968A1
(en)
|
2011-10-03 |
2013-05-16 |
Atossa Genetics, Inc. |
Methods of combining metagenome and the metatranscriptome in multiplex profiles
|
|
GB201117313D0
(en)
*
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
|
PL2750682T3
(pl)
|
2011-10-11 |
2016-10-31 |
|
Kompozycja zawierająca hodowaną beztlenowo ludzką mikroflorę jelitową
|
|
CN104160014A
(zh)
|
2011-12-01 |
2014-11-19 |
国立大学法人东京大学 |
诱导调节性t细胞的增殖或积累的人源细菌
|
|
GB201201766D0
(en)
|
2012-02-01 |
2012-03-14 |
Imp Innovations Ltd |
Method
|
|
WO2013166031A1
(en)
|
2012-04-30 |
2013-11-07 |
The Washington University |
Method of isolating and characterizing microorganisms that are targets of host immune responses
|
|
WO2013171515A1
(en)
|
2012-05-18 |
2013-11-21 |
Genome Research Limited |
Methods and groups
|
|
CA3172599C
(en)
|
2012-05-25 |
2025-10-07 |
Sloan Kettering Institute For Cancer Research |
ANTI-CERAMID ANTIBODY AND RELATED ANTIGEN BINDING FRAGMENT
|
|
US9719144B2
(en)
|
2012-05-25 |
2017-08-01 |
Arizona Board Of Regents |
Microbiome markers and therapies for autism spectrum disorders
|
|
EP2684469A1
(en)
|
2012-07-13 |
2014-01-15 |
Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO |
Methods for strengthening and assessment of the natural defence of the colon against C. difficile overgrowth
|
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
|
WO2014082050A1
(en)
|
2012-11-23 |
2014-05-30 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
|
HK1218559A1
(zh)
|
2013-02-04 |
2017-02-24 |
Seres Therapeutics, Inc. |
抑制致病细菌生长的配方和方法
|
|
EP3904502A3
(en)
|
2013-02-04 |
2022-02-23 |
Seres Therapeutics, Inc. |
Compositions and methods
|
|
WO2014153194A2
(en)
|
2013-03-14 |
2014-09-25 |
Seres Health, Inc. |
Methods for pathogen detection and enrichment from materials and compositions
|
|
AU2014232370B2
(en)
|
2013-03-15 |
2018-11-01 |
Société des Produits Nestlé S.A. |
Network-based microbial compositions and methods
|
|
US9962415B2
(en)
|
2013-05-03 |
2018-05-08 |
Nestec S.A. |
Lachnospiraceae in the gut microbiota and association with body weight
|
|
WO2015018308A1
(en)
|
2013-08-06 |
2015-02-12 |
BGI Shenzhen Co.,Limited |
Biomarkers for colorectal cancer
|
|
CN116370507A
(zh)
|
2013-11-25 |
2023-07-04 |
赛里斯治疗公司 |
协同细菌组合物以及其制造方法和用途
|
|
US9956282B2
(en)
|
2013-12-16 |
2018-05-01 |
Seres Therapeutics, Inc. |
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
|
MA41020A
(fr)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
|
WO2017008026A1
(en)
|
2015-07-08 |
2017-01-12 |
Seres Therapeutics, Inc. |
Methods of treating colitis
|
|
US10300043B2
(en)
|
2015-08-12 |
2019-05-28 |
Mayo Foundation For Medical Education And Research |
Method for treating a gastrointestinal disorder in a mammal using bacteroides thetaiotaomicron and compositions thereof
|
|
WO2017074257A1
(en)
|
2015-10-26 |
2017-05-04 |
Nanyang Technological University |
Non-viable derivatives of clostridium sporogenes as anti-cancer therapeutic agents
|
|
ES2938361T3
(es)
|
2015-11-24 |
2023-04-10 |
Seres Therapeutics Inc |
Composiciones de bacterias diseñadas
|
|
WO2017091753A1
(en)
|
2015-11-25 |
2017-06-01 |
Memorial Sloan-Kettering Cancer Center |
Methods and compositions for reducing vancomycin-resistant enterococci infection or colonization
|
|
IL259480B2
(en)
|
2015-12-14 |
2023-09-01 |
Metabogen Ab |
Treatment of intrahepatic cholestasis and related liver diseases
|
|
WO2017160711A1
(en)
|
2016-03-14 |
2017-09-21 |
Holobiome, Inc. |
Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
|
|
AU2018346255A1
(en)
|
2017-10-03 |
2020-04-23 |
Seres Therapeutics, Inc. |
Manipulation of tryptamine metabolism
|
|
KR20200079292A
(ko)
|
2017-10-30 |
2020-07-02 |
세레스 테라퓨틱스, 인코포레이티드 |
항생제 내성을 치료하기 위한 조성물 및 방법
|
|
CA3101184A1
(en)
|
2018-05-24 |
2019-11-28 |
Seres Therapeutics, Inc. |
Designed bacterial compositions and uses thereof
|